Current projects
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without (±) concurrent posttraumatic stress disorder.
Funding: VA Office of Research & Development
This proof-of-concept randomized controlled clinical trial explores the safety, feasibility, and preliminary efficacy of psilocybin-enhanced psychotherapy versus treatment-as-usual among military Veterans being treated for methamphetamine use disorder within a residential treatment facility.
Funding: Steven & Alexandra Cohen Foundation; OHSU Foundation; study drug provided by Usona Institute
This open-label clinical trial explores the safety, feasibility, and preliminary efficacy of MDMA-assisted group therapy for U.S. military Veterans with PTSD, including long-term follow-up out to 2 years and cost-saving analyses.
SNaP Lab is a site for this Phase 3, randomized, double-blind, multicenter study to evaluate the efficacy, safety, and tolerability of psilocybin in adults with Major Depressive Disorder (MDD).
Many patients with chronic pelvic pain are not adequately helped by current treatments or may experience side effects. Emerging evidence suggests that psilocybin is effective in difficult-to-treat pain syndromes, such as migraines or cluster headaches. This study aims to assess the safety and feasibility of a single dose of psilocybin with supportive therapy to treat chronic pelvic pain and will be the first to evaluate psilocybin therapy for this condition.
Study PIs: Lynne Shinto, ND & Jacq Knapp, MD; Funding: OHSU Women’s Health - Circle of Giving
OPEN is a community-wide, non-commercial, practice-based research network designed to advance public health and collective wisdom by carefully measuring the impact of psychedelic services in non-medical settings (e.g., state-legal services, overseas retreats, etc).







